Atlas Trials

Alpha-Galactosidase A Replacement Therapy for Fabry Disease

Clinical trial NCT00048906 · COMPLETED

Trial details

NCT number
NCT00048906
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2002-11-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.